About this event

  • Date and time Fri 6 Dec 2019 from 12:00pm to 10:00pm
  • Location Royal Society of Medicine
  • Organised by Anaesthesia

Innovative medical devices offer the prospect of revolutionary healthcare. This meeting will explore the complementary perspectives of people, NICE and industry in the development, appraisal and use of these innovations.

Expert speakers will help you understand that engagement of people in the development of medical devices used in anaesthesia and intensive care is different because the loss of consciousness and sedation - meaning patient perspectives of the devices are not available.

You will learn how NICE works in this space and how they want to recommend safe, effective and cost-saving medical devices against the public requirement for effective healthcare at any cost, and industrial considerations for income generation.

Digital technologies on platforms such as smartphones will be considered also, as they may require different types of evidence for clinical efficacy from other medical devices.

There will be ample opportunities for audience and panel discussion, as we consider perspectives from the public, healthcare professionals, industry and NICE.

Key speakers

Mat Campbell-Hill

Senior Fellow at the University of Birmingham College of Medical and Dental Sciences. Past Non-Executive Director of MHRA and past lay member of the Medical Technologies Assessment Committee, National Institute for Health and Care Excellence (NICE).

Chris Pomfrett

Clinical Scientist, Technical Adviser - Research Commissioning, National Institute for Health and Care Excellence (NICE), and Past President of the RSM Anaesthesia Section.


View the programme

Registration, tea and coffee
Introduction and welcome

Dr Samantha Shinde, President, Anaesthesia Section, Royal Society of Medicine

What NICE wants from medical devices

Dr Chris Pomfrett, Clinical Scientist, Technical Adviser - Research Commissioning, National Institute for Health and Care Excellence

Patient Reported Outcome Measures (PROMs) to inform decision making

Dr Kathleen Withers, Cedar Healthcare Technology Research Centre 

Diagnostic testing for sepsis: Procalcitonin

Ruth Poole, Cedar Healthcare Technology Research Centre 

Tea and coffee break
Why accurate data is vital for successful digital technologies

Alex Kafetz, Managing Partner, Director of Insight and Strategy, ZPB Associates, London

What people want from medical devices

Mr Mat Campbell-Hill, Senior Fellow, Novel Medical Technologies, University of Birmingham 

What industry wants from medical devices

Mr Mike Branaghan-Harris, Chief Executive Officer, Device Access UK Ltd

Panel discussion
Closing of meeting
Optional dinner


Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom